<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Breviscapine, a traditional Chinese medicine, is extensively used in clinic to treat <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular diseases</z:e> and cerebrovascular injury </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we demonstrated the effects of breviscapine on vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) rats, which were mimicked by permanent occlusion of bilateral common carotid arteries </plain></SENT>
<SENT sid="2" pm="."><plain>Breviscapine (2 mg/kg for 14 d) improved the performance of learning and memory of VD rats in <z:mp ids='MP_0001465'>Morris water maze</z:mp>, decreased the level of <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation and free radicals, and attenuated the pathological alterations, such as nuclear shrink, cellular <z:hpo ids='HP_0000969'>edema</z:hpo> and irregular arrangement of pyramidal layer in the hippocampal CA(1) area </plain></SENT>
<SENT sid="3" pm="."><plain>In vitro experiment, breviscapine (50 microg/l) protected cortical neuron from injury and decreased intracellular calcium overloading induced by <z:chebi fb="0" ids="30492">H2O2</z:chebi> (10 mM) </plain></SENT>
<SENT sid="4" pm="."><plain>The results suggest that breviscapine has therapeutic effect on <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>